Federal (United States) · Session law
Division A
114 sections
2 groups
28 sections filed directly here
- Pub. L. 114-255, div. A, tit. I, sec. 1001BEAU BIDEN CANCER MOONSHOT AND NIH INNOVATION PROJECTS.Enacted
- Pub. L. 114-255, div. A, tit. I, sec. 1002FDA INNOVATION PROJECTS.Enacted
- Pub. L. 114-255, div. A, tit. I, sec. 1003ACCOUNT FOR THE STATE RESPONSE TO THE OPIOID ABUSE CRISIS.Enacted
- Pub. L. 114-255, div. A, tit. I, sec. 1004BUDGETARY TREATMENT.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4001ASSISTING DOCTORS AND HOSPITALS IN IMPROVING QUALITY OF CARE FOR PATIENTS.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4002TRANSPARENT REPORTING ON USABILITY, SECURITY, AND FUNCTIONALITY.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4003INTEROPERABILITY.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4004INFORMATION BLOCKING.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4005LEVERAGING ELECTRONIC HEALTH RECORDS TO IMPROVE PATIENT CARE.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4006EMPOWERING PATIENTS AND IMPROVING PATIENT ACCESS TO THEIR ELECTRONIC HEALTH INFORMATION.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4007GAO STUDY ON PATIENT MATCHING.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4008GAO STUDY ON PATIENT ACCESS TO HEALTH INFORMATION.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4009IMPROVING MEDICARE LOCAL COVERAGE DETERMINATIONS.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4010MEDICARE PHARMACEUTICAL AND TECHNOLOGY OMBUDSMAN.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4011MEDICARE SITE-OF-SERVICE PRICE TRANSPARENCY.Enacted
- Pub. L. 114-255, div. A, tit. IV, sec. 4012TELEHEALTH SERVICES IN MEDICARE.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5001SAVINGS IN THE MEDICARE IMPROVEMENT FUND.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5002MEDICAID REIMBURSEMENT TO STATES FOR DURABLE MEDICAL EQUIPMENT.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5003PENALTIES FOR VIOLATIONS OF GRANTS, CONTRACTS, AND OTHER AGREEMENTS.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5004REDUCING OVERPAYMENTS OF INFUSION DRUGS.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5005INCREASING OVERSIGHT OF TERMINATION OF MEDICAID PROVIDERS.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5006REQUIRING PUBLICATION OF FEE-FOR-SERVICE PROVIDER DIRECTORY.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5007FAIRNESS IN MEDICAID SUPPLEMENTAL NEEDS TRUSTS.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5008ELIMINATING FEDERAL FINANCIAL PARTICIPATION WITH RESPECT TO EXPENDITURES UNDER MEDICAID FOR AGENTS USED FOR COSMETIC PURPOSES OR HAIR GROWTH.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5009AMENDMENT TO THE PREVENTION AND PUBLIC HEALTH FUND.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5010STRATEGIC PETROLEUM RESERVE DRAWDOWN.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5011RESCISSION OF PORTION OF ACA TERRITORY FUNDING.Enacted
- Pub. L. 114-255, div. A, tit. V, sec. 5012MEDICARE COVERAGE OF HOME INFUSION THERAPY.Enacted